Upregulation of long non-coding RNA HIF 1α-anti-sense 1 induced by transforming growth factor-β-mediated targeting of sirtuin 1 promotes osteoblastic differentiation of human bone marrow stromal cells

Molecular Medicine Reports

Volumn 12, Issue 5, 2015, Pages 7233-7238

  Xu, Yao ^a   Wang, Shilong ^a   Tang, Chaoliang ^a   Chen, Wenjun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Long non coding RNA; Osteoblast differentiation; Sirtuin 1; Transforming growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LONG NON CODING RNA HYPOXIA INDUCIBLE FACTOR 1ALPHA ANTI SENSE 1; LONG UNTRANSLATED RNA; PIRFENIDONE; SIRTUIN 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; HIF1A PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; HOXD10 PROTEIN, HUMAN; LONG NON-CODING RNA HIF 1ALPHA-ANTI-SENSE 1, HUMAN; SIRT1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BONE MARROW STROMA CELL; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL EXAMINATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INVESTIGATIVE PROCEDURES; OSTEOBLAST; OSTEOPOROSIS; PROTEIN ACETYLATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ACETYLATION; CELL CULTURE; GENE EXPRESSION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ACETYLATION; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION; HOMEODOMAIN PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; RNA INTERFERENCE; RNA, LONG NONCODING; SIRTUIN 1; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 84943633087     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4415     Document Type: Article

References (41)

1. Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G: Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754, 1997.
2. Simic P, Zainabadi K, Bell E, Sykes DB, Saez B, Lotinun S, Baron R, Scadden D, Schipani E, Guarente L, et al: SIRT1 regulates differentiation of mesenchymal stem cells by deacetylating β-catenin. EMBO mol Med 5: 430-440, 2013.
3. Backesjo CM, Li Y, Lindgren U and Haldosen LA: Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. J Bone Miner Res 21: 993-1002, 2006.
4. Cohen-Kfir E, Artsi H, Levin A, Abramowitz E, Bajayo A, Gurt I, Zhong L, D'Urso A, Toiber D, Mostoslavsky R and Dresner-Pollak R: Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 152: 4514-4524, 2011.
5. Pfeilschifter J, Bonewald L and Mundy GR: Characterization of the latent transforming growth factor beta complex in bone. J Bone Miner Res 5: 49-58, 1990.
6. Guise TA and Chirgwin JM: Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res (Suppl 415): S32-S38, 2003.
7. Pfeilschifter J and Mundy GR: Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 84: 2024-2028, 1987.
8. Alliston T, Choy L, Ducy P, Karsenty G and Derynck R: TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20: 2254-2272, 2001.
9. Bonewald LF and Dallas SL: Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55: 350-357, 1994.
10. Takeuchi K, Abe M, Hiasa M, Oda A, Amou H, Kido S, Harada T, Tanaka O, Miki H, Nakamura S, et al: Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth. PLoS One 5: e9870, 2010.
11. Volkmann I, Kumarswamy R, Pfaff N, Fiedler J, et al: MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses. Circ Res 113: 997-1003, 2013.
12. Warburton D, Shi W and Xu B: TGF-Smad3 signaling in emphysema and pulmonary fibrosis: An epigenetic aberration of normal development? Amer J Physiol Lung Cell Mol Physiol 304: L83-L85, 2013.
13. Zhao X, Lu Y, Nie Y and Fan D: MicroRNAs as critical regulators involved in regulating epithelial-mesenchymal transition. Curr Cancer Drug Targets 13: 935-944, 2013.
14. Barham G and Clarke NM: Genetic regulation of embryological limb development with relation to congenital limb deformity in humans. J Child Orthop 2: 1-9, 2008.
15. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, et al: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816, 2007.
16. Zuo C, Wang Z, Lu H, Dai Z, Liu X and Cui L: Expression profiling of lncRNAs in C3H10T1/2 mesenchymal stem cells undergoing early osteoblast differentiation. Mol Med Rep 8: 463-467, 2013.
17. Zhu L and Xu PC: Downregulated LncRNA-ANCR promotes osteoblast differentiation by targeting EZH2 and regulating Runx2 expression. Biochem Biophys Res Commun 432: 612-617, 2013.
18. Wang S, Zhang X, Yuan Y, Tan M, et al: BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro. Eur J Cardiothorac Surg 47: 439-446, 2015.
19. Zhao Y, Feng G, Wang Y, Yue Y and Zhao W: Regulation of apoptosis by long non-coding RNA HIF1A-AS1 in VSMCs: Implications for TAA pathogenesis. Int J Clin Exp Pathol 7: 7643-7652, 2014.
20. Yanagita M: Inhibitors/antagonists of TGF-system in kidney fibrosis. Nephrol Dialysis Transplant 27: 3686-3691, 2012.
21. Wu SQ, Wang M, Liu Q, Zhu YJ, Suo X and Jiang JS: Construction of DNA vaccines and their induced protective immunity against experimental Eimeria tenella infection. Parasitol Res 94: 332-336, 2004.
22. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(.Delta Delta C(T)) method. Methods 25: 402-408, 2001.
23. Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q and Zhang J: Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun 425: 468-472, 2012.
24. Kurokawa Y, Matoba R, Nakamori S, Takemasa I, Nagano H, Dono K, Umeshita K, Sakon M, Monden M and Kato K: PCR-array gene expression profiling of hepatocellular carcinoma. J Exp Clin Cancer Res 23: 135-141, 2004.
25. Moustakas A, Pardali K, Gaal A and Heldin CH: Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett 82: 85-91, 2002.
26. Liu D, Black BL and Derynck R: TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15: 2950-2966, 2001.
27. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R and Moses HL: Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139: 541-552, 1997.
28. Qureshi IA and Mehler MF: Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends Mol Med 17: 337-346, 2011.
29. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H and Verdin E: miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY) 2: 415-431, 2010.
30. Srivastava S, Bedi U and Roy P: Synergistic actions of insulin-sensitive and Sirt1-mediated pathways in the differentiation of mouse embryonic stem cells to osteoblast. Mol Cell Endocrinol 361: 153-164, 2012.
31. Bai L, Pang WJ, Yang YJ and Yang GS: Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem 307: 129-140, 2008.
32. Tye CE, Gordon JA, Martin-Buley LA, Stein JL, Lian JB and Stein GS: Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation? J Cell Physiol 230: 526-534, 2015.
33. Hiriart E and Verdel A: Long noncoding RNA-based chromatin control of germ cell differentiation: A yeast perspective. Chromosome Res 21: 653-663, 2013.
34. Bertani S, Sauer S, Bolotin E and Sauer F: The noncoding RNA Mistral activates Hoxa6 and Hoxa7 expression and stem cell differentiation by recruiting MLL1 to chromatin. Mol Cell 43: 1040-1046, 2011.
35. Kretz M: TINCR, staufen1 and cellular differentiation. RNA Biol 10: 1597-1601, 2013.
36. Tajiri N, Acosta SA, Shahaduzzaman M, Ishikawa H, Shinozuka K, Pabon M, Hernandez-Ontiveros D, Kim DW, Metcalf C, Staples M, et al: Intravenous transplants of human adipose-derived stem cell protect the brain from traumatic brain injury-induced neurodegeneration and motor and cognitive impairments: Cell graft biodistribution and soluble factors in young and aged rats. J Neurosci 34: 313-326, 2014.
37. Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, Chun CZ, Samant GV, Zhao B, Garnaas MK, et al: A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115: 133-139, 2010.
38. Orr KS, Shi Z, Brown WM, O'Hagan KA, Lappin TR, Maxwell P and Percy MJ: Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma. J Exp Clin Cancer Res 30: 79, 2011.
39. Hu X, Chen D, Cui Y, Li Z and Huang J: Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10. Sci Rep 3: 3423, 2013.
40. Yallowitz AR, Hrycaj SM, Short KM, Smyth IM and Wellik DM: Hox10 genes function in kidney development in the differentiation and integration of the cortical stroma. PLoS One 6: e23410, 2011.
41. Wu Y, Wang G, Scott SA and Capecchi MR: Hoxc10 and Hoxd10 regulate mouse columnar, divisional and motor pool identity of lumbar motoneurons. Development 135: 171-182, 2008.